JavaScript is disabled.
Some features may not work properly. For the best experience, please enable JavaScript in your browser.
Ledgeburg
Sign In
Loading...
News
Latest
Latest News
Stocks
Discover
Search Stocks
ETFs
Discover
Search ETFs
Funds
Discover
Search Funds
NNNN Financials - Anbio Biotechnology Income & Cash Flow | Ledgeburg
NNNN - Anbio Biotechnology
USD | NASDAQ | Healthcare
Summary
Summary NNNN Stock
Financials
Financials NNNN Stock
Loading...
Loading...
Income Statement
Income Statement NNNN Stock
Balance Sheet
Balance Sheet NNNN Stock
Cash Flow Statement
Cash Flow Statement NNNN Stock
Loading...
Loading...
Home
Stocks
Anbio Biotechnology (NNNN)
Financials
Financials of NNNN
Loading...
Loading...
Loading...
Loading...
Revenue
$8.646844M
Operating Income
$5.76774M
Net Income
$6.403463M
Share Count (Basic)
43.672022M
Operating Cash Flow
$-6.739075M
Free Cash Flow
N/A
Cash And Short-Term Equivalents
$11.901231M
Total Debt
N/A
Annual
Quarterly
Revenue $USD
0
5M
10M
15M
20M
FY2022
FY2023
FY2024
FY2025
Revenue $USD
No data available
Annual
Quarterly
Net Income $USD
0
2M
4M
6M
8M
10M
Annual
Quarterly
Margins
Gross
Operating
Net
0%
20%
40%
60%
80%
FY2022
FY2023
FY2024
FY2025
Net Income $USD
No data available
FY2022
FY2023
FY2024
FY2025
Margins
No data available